Dr Zachary Wallace is a rheumatologist and clinical epidemiology researcher at Massachusetts General Hospital (MGH) and an Assistant Professor of Medicine at Harvard Medical School in Boston, Massachusetts, USA. Dr. Wallace conducts clinical epidemiology research in multi-system rheumatic diseases, particularly IgG4-related disease and ANCA-associated vasculitis, and the impact of COVID-19 on patients with rheumatic disease.
His ultimate goal is to understand how we can leverage disease- and patient-specific factors to guide treatment decisions in a way that maximize patient-oriented outcomes. He is a member of the Steering Committee of the COVID-19 Global Rheumatology Alliance, an international organization studying the impact of COVID-19 on patients with rheumatic diseases and the broader rheumatology community.
His research group is located in the Clinical Epidemiology Program at the Mongan Institute of MGH. He is a member of the Vasculitis and Glomerulonephritis Center as well as the Autoimmune Center of Excellence in IgG4-RD at MGH. His research has been funded by the National Institutes of Health, the Rheumatology Research Foundation, the Executive Committee on Research at MGH, and industry.